Spots Global Cancer Trial Database for HRD Tests for Ovarian cancER
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: HRD Tests for Ovarian cancER
Official Title: HRD Tests for Ovarian cancER
Study ID: NCT06152731
Conditions
Interventions
Study Description
Brief Summary: The study concerns patients with Invasive epithelial ovarian cancer, primary Fallopian tube carcinoma, ovarian-type peritoneal carcinoma, and with an indication of a first-line platinum-based chemotherapy. To determine HRD status, 2 separate tests will be performed in the study: 1. Giscar assay : developed by the sponsor 2. myChoice assay If one or two tests identifies a HRD status : a PARP inhibitor treatment may be initiated according to current recommendations
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Chu Amiens, Amiens, , France
Centre Francois Baclesse, Caen, , France
Centre Oscar Lambret, Lille, , France
Centre Henri Becquerel, Rouen, , France
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
